Simultaneous determination of eight illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry

Through ultra-high performance liquid chromatography-tandem mass spectrometry, the simultaneous detection problem of 8 illegally added chemical drugs in food was solved, and the detection effect of high throughput, high sensitivity and accurate quantity was achieved, reducing the detection cost and time.

CN114113418BActive Publication Date: 2024-11-26CRIMINAL SCI & TECH RES INST OF SHANXI PROVINCIAL PUBLIC SECURITY BUREAU
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111653148.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-30
Publication Date
2024-11-26
Estimated Expiration
2041-12-30

AI Technical Summary

Technical Problem

The prior art lacks eight chemical drugs such as 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropion, bupropion, lacoamide, lufeamide, naltrexone hydrochloride, etc. that are illegally added to food. The simultaneous detection method, and the detection method is inapplicable and the results are inaccurate, resulting in long detection time, high cost and many types of instruments.

Method used

UHP liquid chromatography-tandem mass spectrometry was used to extract and dilute samples by methanol solution, and separated by Waters CORTECS T3 column. Qualitative and quantitative analysis was performed using a liquid-mass chromatography instrument, and the liquid phase and mass spectrometry conditions were optimized to achieve the 8 types. Simultaneous testing of chemical drugs.

Benefits of technology

It has achieved high-throughput, high sensitivity, strong specificity and accurate quantity detection of eight chemical drugs in food, reducing the detection cost and ensuring the accuracy and consistency of the detection results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114113418B_ABST
    Figure CN114113418B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for simultaneously determining eight kinds of illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry, wherein the sample is extracted and diluted by ultrasonic methanol, the chemical drugs can be effectively dissolved in the solution to be tested, and the chemical drugs are separated by a Waters CORTECS T3 chromatographic column, and qualitative and quantitative analysis is performed according to a liquid-mass spectrometer. The method of the present invention can be used for simultaneous qualitative and quantitative determination of eight kinds of chemical drugs, including 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide, and naltrexone hydrochloride, in food, especially food or health food claiming to have weight loss function, to achieve high-throughput detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a qualitative and quantitative detection method for simultaneously determining eight illegally added chemical drugs, including 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide and naltrexone hydrochloride, in food by ultra-high performance liquid chromatography-tandem mass spectrometry, and belongs to the technical field of inspection and detection. Background Art

[0002] At present, with the rapid development of economy and the improvement of people's living standards, foods claiming to have weight loss functions and health foods are very popular among consumers.

[0003] 6-Monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide, naltrexone hydrochloride, these 8 chemical drugs all have a certain degree of weight loss function, and there is a possibility of illegal addition to weight loss function foods and health foods. In the prior art, for the above chemical drugs, only some chemical drugs have detection methods for biological matrices such as plasma, hair, and urine, but there is no detection method for food matrices. When these chemical drugs illegally added to food are detected, due to the different detection matrices, there are problems such as inapplicability of detection methods and inaccurate detection results. In addition, the instruments, mobile phases, and pretreatment methods used in the detection methods of various chemical drugs are not exactly the same. Only one or several of them can be detected each time, resulting in many types of instruments required for detection, long detection time, high cost, etc. 6-Monoacetylmorphine, ketamine, lacosamide, rufinamide, and naltrexone hydrochloride are not included in the illegal addition inspection standards, and there is no literature method for simultaneous determination of the above 8 chemical drugs. Therefore, it is urgent to establish a high-throughput detection method for the simultaneous qualitative and quantitative determination of the above eight chemical drugs in food samples. Summary of the invention

[0004] 1. Technical issues to be resolved

[0005] In order to solve the above problems in the prior art, the present invention provides a method for simultaneously determining 8 kinds of illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry.

[0006] (II) Technical solution

[0007] In order to achieve the above object, the main technical solutions adopted by the present invention include:

[0008] A method for simultaneously determining eight illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry, wherein the illegally added chemical drugs include 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide and naltrexone hydrochloride, comprising the following steps:

[0009] (1) Sample processing: The sample to be tested was fixed to volume with methanol solution, centrifuged, and the supernatant was taken for testing;

[0010] (2) Prepare chemical drug standards of different concentrations for the preparation of standard curves;

[0011] (3) respectively performing liquid chromatography-tandem mass spectrometry on the treated sample solution and the standard;

[0012] Wherein, the liquid chromatography conditions are:

[0013] Mobile phase A: 0.1% formic acid in water; mobile phase B: methanol solution; the gradient system program used is as follows: 0-5 mim, 5% B; 5-21 mim, 5%-98% B; 21-24 mim, 98% B; 24-24.1 mim, 98%-5% B; 24.1-27 mim, 5% B; flow rate: 0.3 mL / min; column temperature: 35 °C; injection volume: 1 μL;

[0014] Mass spectrometry conditions:

[0015] Ion source: ESI source; nebulizer gas flow rate: 3 L / min; heating gas flow rate: 10 L / min; drying gas flow rate: 10 L / min; interface temperature: 300 °C; scanning mode: multiple reaction monitoring mode (MRM);

[0016] The qualitative and quantitative LC-MS / MS analysis parameters of 8 chemical drugs are shown in the following table:

[0017] LC-MS / MS analysis parameters of 8 chemical drugs

[0018]

[0019] Among them, the * is the quantitative ion

[0020] (4) According to the obtained chromatogram of the standard, the chromatogram of the sample solution to be tested is judged accordingly, thereby obtaining the qualitative and quantitative results of the chemical drugs in the sample to be tested.

[0021] In the above method, preferably, in step (1), the sample is processed as follows: for solid samples or liquids, 1 g or 1 mL of the sample is weighed, accurate to 0.001 g, and an appropriate amount of methanol is added to a 25-100 mL volumetric flask, and ultrasonicated for 10-30 min, taken out and cooled, and the volume is fixed to the mark with methanol, and the sample is transferred to a centrifuge tube; centrifuged at 4000 r / min for 5 min, and the supernatant is passed through a 0.22 μm membrane for standby use;

[0022] For high-fat samples, first crush the sample and mix it thoroughly, weigh 1g, accurate to 0.001g, place it in a 25-100mL volumetric flask, add 5mL of ethyl acetate and shake, add an appropriate amount of methanol, ultrasonicate for 10-30min, take out and cool, make up to the scale with methanol, transfer to a centrifuge tube, centrifuge at 4000r / min for 5min, pass the supernatant through a 0.22μm membrane, and set aside.

[0023] In the method as described above, preferably, the food sample to be tested is a functional food, health food or other food with weight loss effect.

[0024] In the above method, preferably, in step (2), the preparation of the standard comprises:

[0025] 1) Standard stock solution: Accurately weigh the standard of each chemical drug and prepare a 100 μg / mL standard stock solution;

[0026] 2) Mixed standard solution: Take 1 mL of the standard stock solution and place it in a 100 mL volumetric flask and dilute to the mark with methanol to obtain a mixed standard solution with a concentration of 1 μg / mL;

[0027] 3) Mixed standard reserve intermediate solution: Measure 1 mL of the mixed standard solution, place it in a 10 mL volumetric flask, and dilute to the mark with methanol to obtain a mixed standard reserve intermediate solution with a concentration of 100 ng / mL;

[0028] 4) Mixed standard working solution: Accurately pipette a certain volume of the above mixed standard reserve intermediate solution into a 10mL volumetric flask, dilute with methanol to prepare mixed standard working solutions with concentrations of 0.5, 1, 2, 5, 10, and 25ng / mL for detection. For the chemical drugs to be tested, mixed standard working solutions of a single or multiple different combinations of 8 chemical drugs can be prepared according to the detection needs.

[0029] In the method as described above, preferably, in step (3), a Waters CORTECS T3 chromatographic column is used for separation in liquid chromatography.

[0030] In the method as described above, preferably, in step (4), during quantitative detection, the extraction chromatogram of the sample solution is obtained, and the concentration of each chemical drug component to be tested in the sample solution is calculated based on the peak area of ​​each chemical drug to be tested and the standard curve of its corresponding standard, and the content of each chemical drug to be tested in the sample solution is converted accordingly.

[0031] (III) Beneficial effects

[0032] The beneficial effects of the present invention are:

[0033] The method provided by the present invention is to simultaneously determine 8 kinds of illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry. The method is to extract and dilute the sample by methanol ultrasonic method, effectively dissolve the chemical drugs to be tested in the test solution, separate by Waters CORTECS T3 chromatographic column, and perform qualitative and quantitative analysis according to liquid-mass spectrometer; the method can simultaneously perform qualitative analysis on 8 kinds of chemical drugs, and optimize and verify the pretreatment methods of different food matrices, so as to ensure the quantitative accuracy of the method. It can realize the simultaneous qualitative and quantitative detection of 8 kinds of chemical drugs such as 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide, and naltrexone hydrochloride in weight loss foods or health foods, and has the advantages of high-throughput detection of 8 kinds of chemical drugs in one detection, high sensitivity, strong specificity, accurate quantification, and low detection cost. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 It is the total ion current diagram of 8 chemical drugs;

[0035] Figure 2 is the chromatogram of phenylpropanolamine;

[0036] Figure 3 is the chromatogram of methamphetamine;

[0037] Figure 4 is the chromatogram of naltrexone hydrochloride;

[0038] Figure 5 is the chromatogram of 6-monoacetylmorphine;

[0039] Figure 6 is the chromatogram of ketamine;

[0040] Figure 7 is the chromatogram of lacosamide;

[0041] Figure 8 is the chromatogram of rufinamide;

[0042] Fig. 9 This is the chromatogram of bupropion. DETAILED DESCRIPTION

[0043] In order to better explain the present invention and facilitate understanding, the present invention is described in detail below through specific implementation modes in conjunction with the accompanying drawings.

[0044] Sources of reagents and instruments used in the following examples: bupropion was purchased from China Food and Drug Inspection Institute; methamphetamine and phenylpropanolamine were purchased from cerilliant; 6-monoacetylmorphine and ketamine were purchased from China Institute of Metrology; rufinamide and naltrexone hydrochloride were purchased from TCI; lacosamide was purchased from TRC; methanol was chromatographically pure, Merck, Germany; ethyl acetate was chromatographically pure, Thermo Fisher, USA; formic acid was chromatographically pure, TCI, Japan. Instruments and equipment used: LCMS 8050 liquid-mass spectrometer (Shimadzu, Japan); XSE205DU electronic balance (Mettler, USA); KQ-500DE numerically controlled ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); MS 3D vortex mixer (IKA, Germany); HC-3018 high-speed centrifuge (Zhongke Zhongjia Company); Waters CORTECS T3 (2.1×100mm, 2.7μm) chromatographic column.

[0045] Example 1

[0046] 1. Solution preparation

[0047] Accurately weigh the following standard substances: bupropion, methamphetamine, phenylpropanolamine, 6-monoacetylmorphine, ketamine, rufinamide, naltrexone hydrochloride, and lacosamide, and prepare them into 100 μg / mL standard stock solutions, and store them in sealed containers at -18°C away from light (valid for 3 months).

[0048] Mixed standard solution: Take 1 mL of each of the above standard stock solutions, place in a 100 mL volumetric flask, dilute to the mark with methanol to obtain a mixed standard solution with a concentration of 1 μg / mL, and store at 4°C (valid for 1 week).

[0049] 2. Optimization of liquid chromatography conditions

[0050] Two mobile phase systems, 0.1% formic acid aqueous solution-methanol and 0.1% formic acid aqueous solution-acetonitrile, were selected to investigate the separation effect of the system. The results showed that in the acetonitrile system, the phenylpropanolamine peak was too early and the retention time was not fixed, which affected the mass spectrometry quantification. Therefore, 0.1% formic acid aqueous solution-methanol system was selected as the mobile phase.

[0051] When optimizing the gradient conditions, it was found that when the initial mobile phase ratio (volume ratio of 0.1% formic acid aqueous solution to methanol) was 90:10, the chemical drug phenylpropanolamine peaked too early, so the initial mobile phase ratio was selected as 95:5, and then the methanol term ratio was increased to 98% from 5 to 21 minutes, so that all the target substances peaked, and the impurities were eluted in the 98% methanol system for 3 minutes, and finally returned to the 5% methanol system for 3 minutes at 24 minutes. Due to the high proportion of water phase in the gradient conditions, in order to protect the chromatographic column, the Waters CORTECS T3 (2.1×100mm, 2.7μm) chromatographic column with better water resistance was selected to replace the general C18 chromatographic column for the next step of research. Under the optimized chromatographic conditions, the 8 chemical drugs achieved good separation effects and met the liquid mass quantification requirements.

[0052] The final optimized liquid chromatography conditions are:

[0053] Mobile phase A: 0.1% formic acid in water; mobile phase B: methanol solution; the gradient system program used is as follows: 0-5 mim, 5% B; 5-21 mim, 5%-98% B; 21-24 mim, 98% B; 24-24.1 mim, 98%-5% B; 24.1-27 mim, 5% B. Flow rate: 0.3 mL / min; column temperature: 35°C; injection volume: 1 μL.

[0054] 3. Optimization of mass spectrometry conditions:

[0055] The single-label stock solution was diluted to 100 ng / mL with methanol, and the single-label solution was injected into the mass spectrometer in positive ion mode. The Q3 Scan full scan mode was first performed to obtain the molecular ion of the chemical drug, and then the parent ion of the compound was determined. Then the PIS mode was selected, and the parent ion was subjected to a fragmentation and rearrangement reaction through argon collision. Two stable and less interfering ion fragments were selected as the qualitative and quantitative ion fragments of the chemical drug. Finally, the qualitative and quantitative ion fragment responses were maximized by optimizing the collision voltage and other factors.

[0056] The mass spectrometry conditions are preferably as follows: ion source ESI source; nebulizing gas flow rate 3 L / min; heating gas flow rate 10 L / min; drying gas flow rate 10 L / min; interface temperature 300° C.; scanning mode: multiple reaction monitoring mode (MRM).

[0057] The optimal ion conditions for each chemical drug were obtained through optimization, as shown in Table 1.

[0058] Table 1. LC-MS / MS analysis parameters of 8 chemical drugs

[0059]

[0060] Among them, the * is the quantitative ion.

[0061] Total ion currents of 8 chemical drugs are shown in Figure 1 In the figure, the eight chemical drugs are arranged in the order of peak elution from left to right: 1. Phenylpropanolamine; 2. Methamphetamine; 3. Naltrexone hydrochloride; 4. 6-monoacetylmorphine; 5. Ketamine; 6. Lacosamide; 7. Rufinamide; and 8. Bupropion.

[0062] Example 2

[0063] 1. Preparation of standard solution: Accurately weigh the following standard substances: bupropion, methamphetamine, phenylpropanolamine, 6-monoacetylmorphine, ketamine, rufinamide, naltrexone hydrochloride, and lacosamide, and prepare them into 100 μg / mL standard stock solutions respectively. Store them in a sealed container at -18°C away from light (valid for 3 months).

[0064] 2. Mixed standard solution: Take 1 mL of each of the above standard stock solutions, place in a 100 mL volumetric flask, dilute to the mark with methanol to obtain a mixed standard solution with a concentration of 1 μg / mL, and store at 4°C (valid for 1 week).

[0065] 3) Mixed standard reserve intermediate solution: Measure 1 mL of the mixed standard solution, place it in a 10 mL volumetric flask, and dilute to the mark with methanol to obtain a mixed standard reserve intermediate solution with a concentration of 100 ng / mL (prepare it before use).

[0066] 4) Mixed standard working solution: Accurately pipette a certain volume of the above mixed standard reserve intermediate solution into a 10 mL volumetric flask, make up to volume with methanol, and prepare mixed standard working solutions with concentrations of 0.5, 1, 2, 5, 10, and 25 ng / mL (prepare immediately before use).

[0067] The mixed standard working solutions prepared above with concentrations of 0.5, 1, 2, 5, 10, and 25 ng / mL were measured according to the detection conditions optimized in Example 1. The standard curve was drawn with the target chemical drug concentration as the horizontal coordinate and the corresponding peak area of ​​the chemical drug quantitative ion pair as the vertical coordinate. The linear correlation coefficient r of the standard curve was used to evaluate its correlation. The specific results are shown in Table 2. The chromatograms corresponding to chemical drugs such as phenylpropanolamine, methamphetamine, naltrexone hydrochloride, 6-monoacetylmorphine, ketamine, lacosamide, rufinamide, and bupropion are shown in Figure 2-Figure 9 shown.

[0068] Table 2 Linear equations and correlation coefficients (r) of 8 chemical drugs

[0069]

[0070] The results show that the correlation coefficients r in the methods of the present invention are all greater than 0.999, which meets the requirements of GB / T 32465-2015 "Requirements for Validation and Internal Quality Control of Chemical Analysis Methods".

[0071] The detection limit of the method was selected based on the signal-to-noise ratio S / N ≥ 3, and the quantification limit was selected based on S / N ≥ 10. The detection limit of the method of the present invention for 8 kinds of compound drugs including 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide and naltrexone in 4 types of food matrices was 25 μg / kg, and the quantification limit was 50 μg / kg; the detection limit (LOD) and quantification limit (LOQ) are shown in Table 3.

[0072] Table 3 Detection limit and quantitative limit

[0073]

[0074] Example 3

[0075] Tablets, beverages, protein powder, and fish oil soft capsule samples were selected respectively, and the samples were classified into general solid, liquid, and high-protein samples: solid samples were crushed and mixed thoroughly, and liquid samples were directly mixed. Weigh 1g of sample (accurate to 0.001g), add 35mL of methanol to a 50mL volumetric flask, and ultrasonically extract for 15min, take out and cool, and dilute to the mark with methanol. The sample was transferred to a 50ml centrifuge tube. Centrifuge at 4000r / min for 5min, and the supernatant was passed through a 0.22μm nylon membrane for use (liquid samples do not need to be centrifuged, and can be directly filtered for use).

[0076] After the high-fat sample is crushed, it is thoroughly mixed. 1 g (accurate to 0.001 g) is weighed and placed in a 50 mL volumetric flask. 5 mL of ethyl acetate is added and shaken. 35 mL of methanol is added and ultrasonic extraction is performed for 15 min. The sample is taken out and cooled. The volume is made up to the mark with methanol. The sample is transferred to a 50 mL centrifuge tube and centrifuged at 4 000 r / min for 5 min. The supernatant is passed through a 0.22 μm nylon membrane for later use.

[0077] Obtain blank sample matrix solution. Prepare mixed standard solutions with a concentration of 10 ng / mL using 4 blank sample matrix solutions and methanol, and measure them on the machine under the conditions optimized in Example 1. Each sample is measured in parallel 3 times, and the peak areas of different chemical drugs in the sample are decomposed and recorded, and the average value is taken to calculate the ME value of different compounds according to the following formula (1).

[0078]

[0079] Where: A-average peak area of ​​target compound in standard solution

[0080] B- Average peak area of ​​target compounds in matrix-added standard solution.

[0081] The ME values ​​of 8 chemical drugs in tablet matrix ranged from 0.83 to 1.04, in beverage matrix from 0.96 to 1.06, in protein powder matrix from 0.85 to 1.12, and in soft capsule matrix from 0.78 to 1.03.

[0082] When ME=1.0, it means there is no matrix effect, 0.8<ME<1.2 is a weak matrix effect, 0.5<ME<0.8 or 1.2<ME<1.5 is a moderate matrix effect, and ME<0.5 or ME>1.5 is a strong matrix effect. The verification results show that there is no strong matrix effect when the above method is used to test the target chemical drugs. Two chemical drugs in the soft capsules have moderate matrix effects, and other chemical drugs and other matrices have weak matrix effects. Therefore, based on comprehensive considerations, a non-matrix standard curve can be used to quantitatively analyze the target compounds.

[0083] Example 4

[0084] Sample processing: For solid samples, crush them and mix them thoroughly; for liquid samples, mix them directly.

[0085] Weigh 1g of sample (accurate to 0.001g), add 35mL of methanol to a 50ml volumetric flask, extract by ultrasonic for 15min, take out and cool, dilute to scale with methanol, transfer the sample to a 50ml centrifuge tube, centrifuge at 4000r / min for 5min, and filter the supernatant through a 0.22μm nylon membrane for later use (liquid samples do not need to be centrifuged, filter directly through the membrane for later use).

[0086] For high-fat samples, mix thoroughly after crushing, weigh 1g (accurate to 0.001g) and place it in a 50mL volumetric flask, add 5mL of ethyl acetate and shake, add 35mL of methanol, ultrasonically extract for 15min, take out and cool, make up to the scale with methanol, transfer to a 50mL centrifuge tube, centrifuge at 4000r / min for 5min, pass the supernatant through a 0.22μm nylon membrane and set aside.

[0087] The mixed standard solution was added to solid high-protein samples such as protein powder and liquid high-fat samples such as fish oil soft capsules at three levels of 50 μg / kg, 100 μg / kg, and 500 μg / kg, and each type of sample was repeated 6 times. The test was performed according to the optimized conditions in Example 1, specifically:

[0088] 1. Chromatographic conditions:

[0089] Mobile phase A: 0.1% formic acid in water; mobile phase B: methanol solution; the gradient system program used is as follows: 0-5 mim, 5% B; 5-21 mim, 5%-98% B; 21-24 mim, 98% B; 24-24.1 mim, 98%-5% B; 24.1-27 mim, 5% B. Flow rate: 0.3 mL / min; column temperature: 35°C; injection volume: 1 μL.

[0090] 2. Mass spectrometry conditions:

[0091] Ion source: ESI source; nebulizing gas flow rate: 3 L / min; heating gas flow rate: 10 L / min; drying gas flow rate: 10 L / min; interface temperature: 300°C; scanning mode: multiple reaction monitoring mode (MRM).

[0092] A standard curve is prepared according to the method in Example 2. The concentration of each target component to be measured in the sample solution is calculated based on the peak area of ​​each target component to be measured and the standard curve of its corresponding standard. Then, the content of each target component to be measured in the sample is obtained according to the following calculation formula (2).

[0093] X=C×V / M, formula (2)

[0094] X-the content of the target component in the sample to be tested, in μg / kg;

[0095] C - concentration of the component to be tested in the test solution, calculated according to the matrix standard curve, in μg / L;

[0096] V - constant volume, in mL;

[0097] M - sample mass, in g.

[0098] The recovery rate and relative standard deviation (RSD) of each chemical drug in different matrices were calculated, and the measurement results are shown in Tables 4 and 5.

[0099] Table 4

[0100]

[0101]

[0102] Table 5

[0103]

[0104] From the values ​​in the table, it can be seen that the recovery rates of the eight chemical drugs in the matrix are between 80.3% and 107.6%, and the precision is between 0.30% and 6.4%, which all meet the relevant provisions of GB / T32465-2015 "Validation and Internal Quality Control Requirements for Chemical Analysis Methods", indicating that the detection method of the present invention has high accuracy.

[0105] Example 5 Detection of actual samples

[0106] 30 batches of foods claiming to have weight loss and health benefits were randomly purchased from the market, and the samples were tested using the detection method established by the present invention. The results were as follows: 8 chemical drugs, including 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide, and naltrexone hydrochloride, were not detected in the 30 batches of samples, and all were negative samples.

[0107] The present invention provides a method for determining eight kinds of illegal weight loss chemical drugs, including 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide and naltrexone hydrochloride, in foods and health foods by using a triple quadrupole liquid-mass spectrometer. The method is applicable to general solid, liquid, high-protein and high-fat samples. It has been verified that the method meets relevant standard requirements in terms of system adaptability, linearity, precision, correctness and stability, and can be used as daily foods, weight loss functional foods and health foods for detecting samples involved in illegal additions. The method has the advantages of simple pre-treatment, accuracy and effectiveness, and can detect eight kinds of chemical drugs at one time by using a liquid-mass spectrometer for high-throughput qualitative and quantitative detection, and has certain promotion value.

[0108] The above is only a preferred embodiment of the present invention, and does not limit the present invention in other forms. Any person skilled in the art can use the above disclosed technical content to change or modify it into an equivalent embodiment with equivalent changes. However, any simple modification, equivalent change and modification made to the above embodiment according to the technical essence of the present invention without departing from the technical solution of the present invention still belongs to the protection scope of the technical solution of the present invention.

Claims

1. A method for simultaneously determining eight illegally added chemical drugs in food by ultra-high performance liquid chromatography-tandem mass spectrometry, characterized in that: The chemical drugs include 6-monoacetylmorphine, methamphetamine, ketamine, phenylpropanolamine, bupropion, lacosamide, rufinamide and naltrexone hydrochloride; It includes the following steps: (1) Sample processing: The sample to be tested was fixed to volume with methanol solution, centrifuged, and the supernatant was taken for testing; (2) Prepare chemical drug standards of different concentrations for the preparation of standard curves; (3) respectively performing liquid chromatography-tandem mass spectrometry on the treated sample solution and the standard; Among them, the liquid chromatography conditions are: Mobile phase A: 0.1% formic acid in water; mobile phase B: methanol solution; the gradient system program used is as follows: 0-5 mim, 5% B; 5-21 mim, 5%-98% B; 21-24 mim, 98% B; 24-24.1 mim, 98%-5% B; 24.1-27 mim, 5% B; flow rate: 0.3 mL / min; column temperature: 35 °C; injection volume: 1 μL; Mass spectrometry conditions: Ion source: ESI source; nebulizer gas flow rate: 3 L / min; heating gas flow rate: 10 L / min; drying gas flow rate: 10 L / min; interface temperature: 300 °C; scanning mode: multiple reaction monitoring mode (MRM); The qualitative and quantitative LC-MS / MS analysis parameters of 8 chemical drugs are shown in the following table: Among them, the ones with * are quantitative ions; (4) according to the obtained chromatogram of the standard, the chromatogram of the sample solution to be tested is judged to be corresponding, thereby obtaining the qualitative and quantitative results of the chemical drugs in the sample to be tested; In step (1), the sample is processed as follows: for solid samples or liquids, 1 g or 1 mL of the sample is weighed, accurate to 0.001 g, and an appropriate amount of methanol is added to a 25-100 mL volumetric flask, and ultrasonicated for 10-30 min. The sample is taken out and cooled, and the volume is fixed to the mark with methanol, and the sample is transferred to a centrifuge tube; centrifuged at 4000 r / min for 5 min, and the supernatant is passed through a 0.22 μm membrane for later use; For high-fat samples, first crush the sample and mix it thoroughly, weigh 1g, accurate to 0.001g, place it in a 25-100mL volumetric flask, add 5mL of ethyl acetate and shake, add an appropriate amount of methanol, ultrasonicate for 10-30min, take it out and cool, dilute to the mark with methanol, transfer it to a centrifuge tube, centrifuge at 4000r / min for 5min, and pass the supernatant through a 0.22μm membrane for later use; In step (3), a Waters CORTECS T3 column is used for separation in liquid chromatography; The food samples to be tested are functional foods, health foods or other foods with weight loss effects; In step (4), during quantitative detection, the extraction chromatogram of the sample solution is obtained, and the concentration of each chemical drug component to be tested in the sample solution is calculated based on the peak area of ​​each chemical drug to be tested and the standard curve of its corresponding standard, and the content of each chemical drug to be tested in the sample solution is converted accordingly.

2. The method according to claim 1, characterized in that In step (2), the preparation of the standard comprises: 1) Standard stock solution: Accurately weigh the standard of each chemical drug and prepare a 100 μg / mL standard stock solution; 2) Mixed standard solution: Take 1 mL of the standard stock solution respectively, place it in a 100 mL volumetric flask and dilute to the mark with methanol to obtain a mixed standard solution with a concentration of 1 μg / mL; 3) Mixed standard reserve intermediate solution: Measure 1 mL of the mixed standard solution, place it in a 10 mL volumetric flask, and dilute to the mark with methanol to obtain a mixed standard reserve intermediate solution with a concentration of 100 ng / mL; 4) Mixed standard working solution: Accurately pipette a certain volume of the above-mentioned mixed standard reserve intermediate solution into a 10mL volumetric flask, dilute to volume with methanol, and prepare mixed standard working solutions with concentrations of 0.5, 1, 2, 5, 10, and 25ng / mL for detection. For the chemical drugs to be tested, prepare mixed standard working solutions of one or more different combinations of 8 chemical drugs according to the detection needs.